FACULTY
John W. Devlin, PharmD, BCPS, FCCM
Associate Professor
School of Pharmacy
Northeastern University
Boston, Massachusetts

David C. Metz, MD
Professor of Medicine
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvannia

ACCREDITATION STATEMENT
Pharmacy
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 809-999-10-093-H01-P
Credits: 1.5 hours (0.15 ceu)

TYPE OF ACTIVITY: Knowledge

Media: Internet

Estimated time to complete activity:
Estimated time to complete this activity is 90 minutes.

PROCEDURE
Please complete the posttest questions and activity evaluation online at: www.powerpak.com (a username and password are required to access your account). Upon passing the exam with a score of 70% or better, you can print out your statement of credit immediately. You can also view your test history at any time and print out duplicate statements from the Web site.

TARGET AUDIENCE
This accredited activity is targeted to pharmacists.

STATEMENT OF NEED/PROGRAM OVERVIEW
The goal of this program is to acquaint pharmacists and allied healthcare professionals with the appropriate use of proton pump inhibitors (PPIs) available “over the counter” (OTC) for frequent heartburn.

EDUCATIONAL OBJECTIVES

1. Define frequent heartburn
2. Describe how to take a focused clinical history to exclude other possible causes of heartburn-like symptoms
3. Identify appropriate individuals for self-treatment with an OTC PPI
4. Discuss the dose selection, efficacy, and rationale for use of OTC PPIs in individuals with frequent heartburn
5. Explain possible long-term consequences of PPI use and place these in appropriate perspective.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this activity:

John W. Devlin, PharmD, BCPS, FCCM has disclosed the following: Non-CME Fees from Takeda Pharmaceuticals.

David C. Metz, MD has disclosed the following: Consulting Fees from Novartis Consumer Health, Takeda Pharmaceuticals, Xenaport, and Novartis Pharmaceutical/Oncology; Contracted Research from Xenaport; Ownership Interest with Johnson & Johnson.

The following PIM planners and managers, Jan Hixon, RN, BSN, MA, Trace Hutchison, PharmD, Julia Kimball, RN, BSN, Samantha Mattiucci, PharmD, Patricia Staples, MSN, NP-C, CCRN; and Jan Schultz, RN, MSN, CCMEP hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following SCI planners and managers, Elena Urso and Alison Howe, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unlabeled Use and Disclaimer
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM and Novartis Consumer Health, Inc. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer’s package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.